Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NeueHealth | NEUE | Jan 17, 2025 | 7.45 | +1.09 |
Neumora Therapeutics | NMRA | Jan 17, 2025 | 2.05 | -5.53 |
Neuphoria Therapeutics | NEUP | Jan 17, 2025 | 3.15 | 0.00 |
Neuraxis | NRXS | Jan 17, 2025 | 2.85 | +11.33 |
Neurocrine Biosciences | NBIX | Jan 17, 2025 | 143.26 | +0.94 |
Neurogene | NGNE | Jan 17, 2025 | 16.60 | -5.84 |
NeuroMetrix | NURO | Jan 17, 2025 | 4.05 | +3.05 |
Neuronetics | STIM | Jan 17, 2025 | 2.46 | +7.89 |
NeuroOne | NMTC | Jan 17, 2025 | 1.05 | +0.95 |
Neuropace | NPCE | Jan 17, 2025 | 11.97 | +0.50 |
NeuroSense Therapeutics | NRSN | Jan 17, 2025 | 1.09 | -2.68 |
Nevro | NVRO | Jan 17, 2025 | 4.57 | +1.56 |
New America High Income Fund | HYB | Jan 17, 2025 | 8.22 | -0.36 |
New Century Logistics (BVI) Limited - Ordinary Shares | NCEW | Jan 17, 2025 | 1.72 | 0.00 |
New Concept Energy | GBR | Jan 17, 2025 | 1.18 | -1.33 |
New England Realty Associates LP Unit A | NEN | Jan 17, 2025 | 80.88 | -2.71 |
New Era Helium | NEHC | Jan 17, 2025 | 2.99 | 0.00 |
New Fortress Energy A | NFE | Jan 17, 2025 | 16.29 | +2.32 |
New Found Gold | NFGC | Jan 17, 2025 | 1.71 | -1.16 |
New Germany Fund | GF | Jan 17, 2025 | 7.87 | +0.38 |
New Gold | NGD | Jan 17, 2025 | 2.75 | 0.00 |
New Horizon Aircraft | HOVR | Jan 17, 2025 | 0.90 | -0.40 |
New Mountain Finance Corp | NMFC | Jan 17, 2025 | 11.27 | +0.45 |
New Oriental Education & Technology Group ADR | EDU | Jan 17, 2025 | 60.84 | +2.77 |
New Pacific Metals | NEWP | Jan 17, 2025 | 1.24 | +2.92 |
New Providence Acquisition II Unit | NPABU | Jan 17, 2025 | 12.20 | 0.00 |
New Residential Investment A Pref | RITM-A | Jan 17, 2025 | 25.73 | -0.21 |
New Residential Investment B Pref | RITM-B | Jan 17, 2025 | 25.62 | +0.04 |
New Residential Investment C Pref | RITM-C | Jan 17, 2025 | 24.96 | -0.16 |
New Residential Investment D Pref | RITM-D | Jan 17, 2025 | 24.17 | +0.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.